Prokidney (PROK) Enterprise Value (2021 - 2026)
Prokidney (PROK) posted quarterly Enterprise Value of -$101.9 million for Q1 2026, down 4.18% year-over-year from -$106.3 million in Q1 2025, and up 6.12% quarter-over-quarter from -$108.5 million in Q4 2025.
Prokidney (PROK) Enterprise Value (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Enterprise Value for 6 consecutive years, with -$101.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 4.18% year-over-year to -$101.9 million; the TTM figure through Mar 2026 stood at -$101.9 million (down 4.18% YoY), while the FY2025 annual figure was -$108.5 million, down 9.5% from the prior year.
- Enterprise Value rose to -$101.9 million in Q1 2026 per PROK's latest filing, from -$108.5 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$60.6 million in Q4 2023 and bottomed at -$506.3 million in Q3 2022.
- Historically, Enterprise Value has averaged -$183.9 million across 5 years, with a median of -$108.1 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 2284.73% — and 2023, when it surged 87.63%.
- Prokidney's Enterprise Value stood at -$490.3 million in 2022, then soared by 87.63% to -$60.6 million in 2023, then tumbled by 63.43% to -$99.1 million in 2024, then declined by 9.5% to -$108.5 million in 2025, then advanced by 6.12% to -$101.9 million in 2026.
- Business Quant data shows PROK's Enterprise Value at -$101.9 million in Q1 2026, -$108.5 million in Q4 2025, and -$95.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | -181.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -181.56 Mn |
| Mar 31, 2026 | -101.90 Mn |
| Dec 31, 2025 | -108.54 Mn |
| Sep 30, 2025 | -95.32 Mn |
| Jun 30, 2025 | -84.94 Mn |
| Mar 31, 2025 | -97.81 Mn |
| Dec 31, 2024 | -99.12 Mn |
| Sep 30, 2024 | -108.09 Mn |
| Jun 30, 2024 | -214.51 Mn |
| Mar 31, 2024 | -84.39 Mn |
| Dec 31, 2023 | -60.65 Mn |
| Sep 30, 2023 | -191.39 Mn |
| Jun 30, 2023 | -243.55 Mn |
| Mar 31, 2023 | -271.64 Mn |
| Dec 31, 2022 | -490.25 Mn |
| Sep 30, 2022 | -506.33 Mn |
| Dec 31, 2021 | -20.56 Mn |